Nascent Pharma Holdings, Inc. (NASC)
OTCMKTS · Delayed Price · Currency is USD
0.01249
+0.00099 (8.61%)
At close: Mar 27, 2026

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Durable Equipment Products
2.16M6.69M4.60M1.71M2.31M
Durable Equipment Products Growth
-67.76%45.22%169.28%-25.84%244.82%
Total
2.16M6.69M4.60M1.71M2.31M
Total Growth
-67.76%45.22%169.28%-25.84%244.82%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
United States
2.16M6.69M4.60M1.71M2.31M
United States Growth
-67.76%45.22%169.28%-25.84%244.82%
Total
2.16M6.69M4.60M1.71M2.31M
Total Growth
-67.76%45.22%169.28%-25.84%244.82%
Source: S&P Global Market Intelligence.